Reviva Pharmaceuticals Holdings Inc.

09/09/2024 | Press release | Distributed by Public on 09/09/2024 06:09

Reviva Announces New Vocal Biomarker Data from Phase 3 RECOVER Trial of Brilaroxazine in Schizophrenia Earnings Release